- Home
- IP vs HOLX Comparison
IP vs HOLX Comparison
Compare IP & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IP | HOLX |
|---|---|---|
| Founded | 1898 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Paper | Medical Electronics |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.6B | 16.6B |
| IPO Year | N/A | 1990 |
Fundamental Metrics
Financial Performance| Metric | IP | HOLX |
|---|---|---|
| Price | $38.30 | $74.92 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 8 | 15 |
| Target Price | $50.00 | ★ $79.64 |
| AVG Volume (30 Days) | ★ 4.8M | 2.9M |
| Earning Date | 01-29-2026 | 02-04-2026 |
| Dividend Yield | ★ 4.79% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.49 |
| Revenue | ★ $24,334,000,000.00 | $4,100,500,000.00 |
| Revenue This Year | $35.00 | $6.69 |
| Revenue Next Year | $1.05 | $5.74 |
| P/E Ratio | ★ N/A | $30.10 |
| Revenue Growth | ★ 47.35 | 1.74 |
| 52 Week Low | $35.56 | $51.90 |
| 52 Week High | $60.15 | $75.34 |
Technical Indicators
Market Signals| Indicator | IP | HOLX |
|---|---|---|
| Relative Strength Index (RSI) | 45.14 | 62.25 |
| Support Level | $38.24 | $74.89 |
| Resistance Level | $39.24 | $75.19 |
| Average True Range (ATR) | 0.87 | 0.25 |
| MACD | 0.16 | -0.12 |
| Stochastic Oscillator | 40.04 | 46.20 |
Price Performance
Historical ComparisonAbout IP International Paper Company
International Paper manufactures packaging products and cellulose fibers. It accounts for roughly one-third of the North American corrugated packaging market. The company also has a substantial presence in Europe following its acquisition of DS Smith. International Paper serves a variety of end markets, including industrial, consumer products, and manufacturing.
About HOLX Hologic Inc.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.